Human CD4+CD25hiFoxp3+CD127 Treg and CD4+ CD25Foxp3 Tconv cell functions are governed by their metabolic requirements. Here we report a comprehensive comparative analysis between ex vivo human Treg and Tconv cells that comprises analyses of the proteomic networks in subcellular compartments. We identified a dominant proteomic signature at the metabolic level that primarily impacted the highly-tuned balance between glucose and fatty-acid oxidation in the two cell types. Ex vivo Treg cells were highly glycolytic while Tconv cells used predominantly fatty-acid oxidation (FAO). When cultured in vitro, Treg cells engaged both glycolysis and FAO to proliferate, while Tconv cell proliferation mainly relied on glucose metabolism. Our unbiased proteomic analysis provides a molecular picture of the impact of metabolism on ex vivo human Treg versus Tconv cell functions that might be relevant for therapeutic manipulations of these cells.

The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements.

Claudio Procaccini;Fortunata Carbone;Dario Di Silvestre;Francesca Brambilla;Veronica De Rosa;Mario Galgani;Marco Corona;Giuseppe Matarese
2016

Abstract

Human CD4+CD25hiFoxp3+CD127 Treg and CD4+ CD25Foxp3 Tconv cell functions are governed by their metabolic requirements. Here we report a comprehensive comparative analysis between ex vivo human Treg and Tconv cells that comprises analyses of the proteomic networks in subcellular compartments. We identified a dominant proteomic signature at the metabolic level that primarily impacted the highly-tuned balance between glucose and fatty-acid oxidation in the two cell types. Ex vivo Treg cells were highly glycolytic while Tconv cells used predominantly fatty-acid oxidation (FAO). When cultured in vitro, Treg cells engaged both glycolysis and FAO to proliferate, while Tconv cell proliferation mainly relied on glucose metabolism. Our unbiased proteomic analysis provides a molecular picture of the impact of metabolism on ex vivo human Treg versus Tconv cell functions that might be relevant for therapeutic manipulations of these cells.
2016
Istituto di Endocrinologia e Oncologia Sperimentale ''G. Salvatore'' - IEOS
Istituto di genetica e biofisica "Adriano Buzzati Traverso"- IGB - Sede Napoli
Istituto di Tecnologie Biomediche - ITB
Treg
Tconv
Proteomics
fatty-acid oxidation
glycolysis
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/308151
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 147
  • ???jsp.display-item.citation.isi??? ND
social impact